The 20 Best Epithelial-Myoepithelial Carcinoma Doctors Near Me in New York, US

. Dr. Redd is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Infant Hearing Loss, DFNB1, Jones Syndrome, and Meniere Disease.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy. Dr. Singh is board certified in American Board Of Otolaryngology.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as an Advanced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

I strive to provide the best and most current techniques in head and neck surgery. Following my training at the University of Toronto, Cedars Sinai in Los Angeles and Sloan Kettering here in NY, I was appointed as Residency Director at Manhattan Eye Ear Throat Hospital. Since 1987, I have been in private practice in Manhattan and Queens, where I am the Chief of the Head and Neck Service. I have had over 30 years of experience dealing with tumors in this region.My interests include thyroid and parathyroid surgery, salivary gland surgery, cancers of the oral cavity and larynx and the treatment of sinusitis. Nerve monitoring during complex surgery is frequently utilized.This is a solo practice so all patients are seen and treated by myself, both in the office and in the operating room. Dr. Shemen is rated as an Advanced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Nonsyndromic Hearing Loss, Deafness Hypogonadism Syndrome, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Swallowing Difficulty, and Thyroidectomy. Dr. Shemen is board certified in American Board Of Otolaryngology.

Alan Ho is an Otolaryngologist practicing medicine in New York, New York. Dr. Ho is rated as a Distinguished provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Thyroid Cancer, and Follicular Thyroid Cancer. Dr. Ho is currently accepting new patients.

Dev Kamdar is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Kamdar is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy. Dr. Kamdar is board certified in American Board Of Otolaryngology.

Lucio Pereira is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Pereira is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Pereira is board certified in American Board Of Otolaryngology.

Richard V. Smith, MD, FACS, is Chair, Otorhinolaryngology-Head & Neck Surgery, Professor, Otorhinolaryngology-Head & Neck Surgery, Professor, Surgery and Professor, Pathology at Montefiore Einstein. Dr. Smith’s clinical focus is on head and neck surgery, including transoral robotic and laser surgery for throat and larynx cancer, salivary gland, thyroid and parathyroid surgery. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Parathyroidectomy.

Dr. Mittelman earned his medical degree from his medical degree from Mt. Sinai School of Medicine. He completed his internship at Elmhurst Hospital Center, Queens, and his internal medicine residency at State University of NY Health Science Center, Brooklyn. He completed a fellowship in oncology at Memorial Sloan Kettering Cancer Center in July 1983. Dr. Mittelman is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Colorectal Cancer.

Dr. Ames is passionate about research, development and implementation of cutting-edgetreatment modalities, as well as tried-and-true protocols. He enjoys the challengingacademic environment of the NSLIJ system and participating in successful treatment ofvaried malignancies utilizing state-of-the-art techniques such as: Intensity ModulatedRadiotherapy (IMRT); Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT);High Dose Rate Brachytherapy (HDR) for partial breast , skin and GYN malignancies, and otherprogressive treatments.Dr. Ames is committed to the holistic management of cancer and supports the integration ofcomplementary modalities (i.e. yoga, meditation, acupuncture, nutrition) in all treatmentregimens. Dr. Ames is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Anal Cancer, Cervical Cancer, and Pleuropulmonary Blastoma. Dr. Ames is board certified in American Board Of Radiology/Radiation Oncology.

Dr. Vainshtein is a radiation oncologist with the White Plains Hospital Cancer Program. Dr. Vainshtein is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Anal Cancer, and Laryngeal Cancer.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

I am a board certified medical oncologist treating all solid tumor malignancies,with special expertise in gastrointestinal malignancies, gynecological malignancies and head and neck cancer. I am the Director of GI Malignancies for the Eastern Region at Northwell Health Cancer Institute, and Chief of Hematology Oncology at Huntington Hospital. I collaborate with a multidisciplinary team of physicians, surgeons, radiation oncologists, pathologists, and radiologists to bring the best possible care to patients who wish to be treated close to home on Long Island. I am also an attending physician of the Don Monti Division of Medical Oncology and Hematology at North Shore University Hospital, Long Island Jewish Medical Center and Southside Hospital. Prior to joining Northwell Health, I was an attending physician at Memorial Sloan Kettering Cancer Center. I completed my Internal Medicine residency training at Maimonides Medical Center and my fellowship in Hematology and Oncology at the University of Vermont. In addition to my work as a clinician, I have a strong interest in clinical research. I immensely enjoy teaching and have mentored many young physicians during their training. I am proud to be part of a dedicated multidisciplinary team, providing state- of-the-art comprehensive care to all of our patients on Long Island. Dr. Siebel is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Merkel Cell Carcinoma, and Lynch Syndrome. Dr. Siebel is board certified in American Board Of Internal Medicine/Medical Oncology.

"Andrew Salama, DDS, MD, is the chief of oral and maxillofacial surgery at Long Island Jewish Medical Center at Northwell. He specializes in head and neck cancer and microvascular reconstruction.Dr. Salama's path toward his specialty actually began in the waiting room of his oral and maxillofacial surgeon, when he was preparing to get his wisdom teeth removed as a college student. Amid the usual magazines were medical journals describing surgeries related to oral and maxillofacial surgery.""I thought it was fascinating, and that led to dental school,"" he recalls. ""On my very first day there, one of the oral and maxillofacial faculty presented a lecture on head and neck cancer, and I remember thinking, 'I want to do that.' It seemed like a dynamic specialty with evidence-based practice, and also one that offered the opportunity to build strong and longitudinal doctor-patient relationships.""After graduating from the University of Maryland Dental School in 1999, Dr. Salama attended the University of Maryland School of Medicine, graduating in 2002. He did his residency in oral and maxillofacial surgery and then completed a two-year fellowship in head and neck oncologic surgery. He remained on faculty for four years before moving to Boston as the director of maxillofacial oncology at Boston University Medical Center. After 11 years in Boston, he joined Northwell in July 2021 with the aim of blending his leadership skills with patient care.""Surgeons only spend about 15 to 20% of their time actually performing surgery, which means it's crucial to find activity that makes the other 80% of time meaningful,"" Dr. Salama explains. ""People simply like working at Northwell; it's a happy place that provides high-quality health care. I came here because it's a supportive environment that is dedicated to positive patient outcomes.""Although Dr. Salama enjoys keeping up with the innovations in his field and drawing on the collaborative environment within Northwell, what he appreciates most in his role are the connections he makes with patients.""There's magic there, when you're working together toward better health,"" he says. ""The relationship and trust between doctors and patients is a large part of what meaningful health care is about. Interacting with patients and their families, and finding solutions to their problems, is what makes me excited to come in every day.""". Dr. Salama is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Ewing Sarcoma, Oral Squamous Cell Carcinoma, Osteotomy, and Glossectomy. Dr. Salama is board certified in American Board Of Oral & Maxillofacial Surgery.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Jocelyn Wozney is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Wozney is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Familial Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Wozney is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Ashwatha Narayana practices at Northern Westchester Hospital and Phelps Hospital. Dr. Narayana is a member of the American Society for Radiation Oncology; the American Board of Radiology; the American Society of Clinical Oncology; the Society of Neuro-Oncology; the Indian Society of Neuro-Oncology; the Indian College of Radiation Oncology; the Association of Radiation Oncologist of India; and the Indo-American Cancer Association. He has also been involved in a variety of community and humanitarian projects that include conducting prostate cancer and breast cancer screening programs and helping improve quality and access to cancer therapy in developing countries in South East Asia, as part of American Society of clinical Oncology (ASCO) and Heath Volunteer Overseas (HVO).As part of the Northwell Health Cancer Institute at Northern Westchester Hospital, Dr. Narayana works with the multidisciplinary team to enhance existing services that include Intra-operative radiation therapy (IORT), high dose rate brachytherapy, (HDR), stereotactic body radiotherapy (SBRT) and Gamma Knife (GK) programs. He has brought skin brachytherapy to Northern Westchester Hospital, which offers patients a shorter course of treatment that can be completed in five to six visits over two weeks with local control and excellent cosmetic results. Dr. Narayana has led institutional teams to set-up brachytherapy, stereotactic radiosurgery programs, and oncology workshops in Russia, India and Nepal.His most recent project at Northern Westchester Hospital is Space OAR therapy for metastatic prostate cancer, which offers pain relief and excellent quality-of-life outcomes.Dr. Narayana has published more than 80 peer reviewed original articles and 15 book chapters and has given over 120 lectures as an invited speaker around the world. He has won numerous awards and honors including membership in The National Comprehensive Cancer Network (NCCN) in Central Nervous System Panel. He serves as an associate editor for the journal of clinical research and therapeutics as well as medical physics and is a reviewer for many oncology journals, including Journal of clinical oncology, Cancer research, Red journal and Neurosurgery. Dr. Narayana is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Posterior Fossa Tumor, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Gamma Knife Radiosurgery. Dr. Narayana is board certified in American Board Of Radiology/Radiation Oncology.

Dr. Laurent Ganry provides surgical answers to facial deformities from diverse origins, restoring dignity for his patients and obtaining esthetic and functional results, while using a patient-centered approach.Dr. Ganry's pursuit of excellence led him to undertake dual fellowships training in Head & Neck OMFS & ENT surgery, combined with a plastic surgery fellowship in Tokyo, Japan, broadening his perspective and skills. He has received multiple awards in surgical innovations and international reconstructive microsurgery competitions, developed a patented medical device in the USA, and published over 30 scientific articles and book chapters.With two decades of experience, Dr. Ganry has honed his skills and knowledge as an attending surgeon in prestigious institutions, such as the Plastic & Reconstructive Surgery Department of Henri Mondor Academic Hospital and the ENT / Head and Neck Surgery Department of Gustave Roussy Cancer Center in France. Dr. Ganry is rated as undefined provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. His clinical expertise encompasses Basal Cell Skin Cancer, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Bone Graft, and Osteotomy.

Sagar Rakshit is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Rakshit is rated as an Experienced provider by MediFind in the treatment of Epithelial-Myoepithelial Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Polymorphous Low Grade Adenocarcinoma, and Pleuropulmonary Blastoma.